Introduction Patients undergoing major hepatectomy are at increased risk for post-operative morbidity and mortality, and changes in the phenotype of effector cells may predispose these patients to infectious sequelae. Methods To better understand post-hepatectomy immune responses, peripheral blood from 15 hepatectomy patients was drawn immediately before and after liver resection and on post-operative days 1, 3, and 5. Circulating monocytes and dendritic cells were analyzed by flow cytometry for quantity, phenotype, activation status, human leukocyte antigen DR (HLA-DR) expression, and toll-like receptor-2 and -4 expression. Results Major hepatectomy increased the numbers of activated CD16 bright blood monocytes and the percentage of activated dendritic cells, although monocyte HLA-DR expression was reduced. These results may represent both dysfunctional antigen presentation and pending anergy, as well as cellular priming of immune effector cells. Better understanding of the alterations in innate immunity induced by hepatectomy may identify strategies to reduce infectious outcomes.
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Introduction
Liver resection is an effective treatment for many benign and malignant diseases, and in the past decade, significant advances have been made in reducing post-operative mortality of hepatectomy patients [16] . Infections and sepsis are among the most common post-hepatectomy complications, with post-operative infectious complications occurring in 4-20% of these patients [6, 12, 13, 16, 22] . Even in institutions with improved morbidity and mortality rates after hepatectomy, post-operative infections and sepsis still have an increased association with mortality and can account for up to 40% of post-operative deaths [6, 12, 13, 16, 22] . The mechanism(s) behind this increased risk of infection and subsequent mortality in patients after liver resection remains unclear. One possible mechanism could be surgery and/or hepatic injury-induced changes in innate immunity. Two of the key cells of innate immunity include monocytes and dendritic cells (DCs). Circulating monocytes have been demonstrated to play a central role in the innate immune response, and among this cell population, it is thought that the CD16 bright (Fcγ receptor III expressing) subpopulation is of critical importance [5, 50] . CD16 bright monocytes are more mature, have an increased activation status, play a greater role in cytokine secretion, and are more responsible for monocyte/T-cell interactions than their CD16 dim counterparts [5, 33, 41] . The CD16 bright monocyte subpopulation is known to expand during sepsis [14] .
DCs are the most potent antigen presenting cell and serve as a critical link between the innate and acquired immune systems [10] . Peripheral DCs contain several subsets, which include DC1, DC2, and less differentiated subtypes. In humans, DC1s are predominantly myeloid DCs that express CD11c (p150, integrin α chain) and are thought to be the more immunogenic of the DC subtypes [4, 17, 36, 37] . DC2s are plasmacytoid DCs, so-called due to their morphology, and they express CD123 (IL-3 receptor α chain) [34] . The DC2 subtype is thought to be the more tolerogenic subset, with the capacity to generate either a Th 2 response, anergy or antigen-specific nonresponsiveness [17, 23, 25, 37] . Finally, an additional DC subtype has been characterized as a less differentiated DC (ldDC). These cells have been described predominantly in fetal cord and pediatric blood samples [18, 29, 45] . The number of these cells in the systemic circulation decreases with age, similar to other immature cell types. However, the origin, function, and migration pattern of these cells have yet to be fully elucidated [18, 29, 45] .
With the key roles that monocytes and DCs play in innate immunity and their link to the acquired immune system, changes in these cell numbers and phenotype may explain some of the immune dysfunction that has been seen in patients undergoing hepatic resection. Our goal was to analyze circulating monocyte and DC numbers and phenotype in the immediate pre-operative and post-operative period in patients undergoing hepatectomy. We hypothesized that the phenotypic changes in blood monocytes and DCs following hepatectomy would be consistent with a reduced capacity for immune surveillance.
Materials and Methods
The University of Florida Institutional Review Board approved this study. Informed signed consent was obtained from all patients prior to inclusion in the study.
Patients Fifteen adult patients (≥21 years) undergoing major hepatic resection were prospectively analyzed (Table I) . Exclusion criteria included: evidence of active systemic or localized infection at the time of surgery, infection with HIV, previous organ transplant, current immunosuppressive treatments, current use of steroids or non-steroidal anti-inflammatory medications, previous hepatic resection, or arterial chemoembolization or radiofrequency ablation less than 3 months prior to surgery. Patients with planned complex combined hepatic reception with vascular reconstruction that might lead to increased liver ischemic injury were also excluded.
Surgical Technique All surgery was performed by a single surgeon (AWH) and was standardized. Briefly, the abdomen was opened and assessed for evidence of extrahepatic disease or unresectability. Intra-operative ultrasound was performed to assess the extent of intrahepatic disease. The liver was mobilized by dividing the triangular ligaments and by mobilizing the liver off of the inferior vena cava. Extrahepatic control of the hepatic veins was achieved prior to parenchymal transection of the liver. In order to standardize the ischemic injury sustained by the liver, 30 min of hepatic arterial and portal venous inflow occlusion (Pringle maneuver) was used in all cases during the parenchymal transaction phase of the procedure. In the two cases that required portal venous reconstruction, the reconstruction was performed during the 30 min of inflow occlusion; however, additional dissection of the portal vein was required in order to obtain distal control. Parenchymal transection was performed using low central venous pressure conditions and the liver divided with an ultrasonic aspirator.
Samples Blood samples were obtained from central or peripheral venous access at the following time points: after laparotomy prior to mobilization of the liver, 30 min postresection of the liver prior to closure of the abdomen, and post-operative days (POD) 1, 3, and 5. Initially, 2 ml of blood was withdrawn into a separate container and discarded. Next, blood was withdrawn into a 3-ml Becton Dickinson Vacutainer™ K 3 EDTA tube (BD, Franklin Lakes, NJ, USA), placed on ice, and immediately processed. In addition, an extra aliquot of blood was collected into another 3-ml Vacutainer™ K 3 EDTA tube for determination of a complete and differential blood count.
Flow Cytometry Blood from the first Vacutainer™ K 3 EDTA tube was transferred into six polystryrene 12× 75 mm test tubes (Fischer Scientific, Pittsburg, PA,USA) for fluorescent antibody staining, three for DCs (200 μl each) and three for monocytes (100 μl each). DC staining was performed as previously described with some minor modifications [48] . The following antibodies were utilized to phenotype DCs: fluorescein conjugated (FITC)-Lineage Cocktail (CD3, 14, 16, 19, 20, 56) , R-phycoerythrin conjugated (PE)-CD123, peridinin chlorphyll protein conjugated (PerCP)-DR, allophycocyanin conjugated (APC)-CD11c, PE-CD86 (BD Biosciences, San Jose, CA, USA), PE-TLR2, and APC-TLR4 (eBioscience, San Diego, CA, USA). The following antibodies were used to phenotype blood monocytes: FITC-CD16, PE-CD11b, PerCP-CD14, APC-CD18, FITC-CD69, PE-CD16, PerCP-DR, APC-CD14 (BD Biosciences), PE-TLR2, and APC-TLR4 (eBioscience). Appropriate isotype controls were run with blood obtained from healthy controls and used for compensation and gating blood samples from the hepatectomy patients. In addition, gating was performed on blood from healthy subjects after being incubated for 1 h at 37°C with and without 1 μg/ml lipopolysaccharide (LPS; Sigma, St. Louis, MO, USA) to guarantee appropriate detection of markers of DC and monocyte activation by flow cytometry. After the addition of the antibody cocktail, all tubes were gently mixed and left for 20 min in the dark. During this time Flow Cytometry Analysis Compensation and isotype gating were performed prior to hepatectomy sample acquisition using blood from healthy non-hepatectomy control subjects. For DC analysis, debris (events too small to be considered cells) was eliminated using a forward versus side scatter density plot. Subsequently, the remaining events were gated to a Lineage Cocktail versus HLA-DR density plot, on which DCs were identified as being Lineage Cocktail − and HLA-DR + events (Fig. 1a ). These cells were analyzed for their expression of CD123 and CD11c to determine their phenotype (DC1 = CD11c + , DC2 = CD123 + , ldDC CD11c − CD123 − ; Fig. 1b ). Activation status was determined by expression of CD86. TLR-2 and TLR-4 expression were also identified. Monocyte analysis used a mixture of forward and side scatter characteristics as well as the CD14 marker in order to isolate CD16 bright/dim monocytes for analysis. Like the DC analysis, monocyte analysis used a forward versus side scatter density plot to eliminate debris. However, lymphocytes were also eliminated on this plot. Non-debris, non-lymphocyte events were then gated to a CD14 histogram. CD14 + events were then back gated to a forward versus side scatter plot and a gate was drawn around the apparent cells. Next, the gate only (not the cells) was copied back into the original non-debris non-lymphocyte forward versus side scatter density plot (which had no gating based on CD14). The events in the forward versus side scatter plot that were contained in this newly copied region were then gated to a CD14 versus CD16 plot, which allowed determination of CD16 bright/dim monocytes (Fig. 1c) . This form of monocyte analysis was necessary for the following reasons: gating on a CD14 histogram alone would have excluded some CD16 bright monocytes which are CD14 low ; and gating on forward and side scatter characteristics alone would not always allow complete the differentiation between monocytes or granulocytes, causing either the exclusion of some monocytes or the inclusion of some granulocytes in the monocyte analysis. These monocytes were analyzed for their expression of activation markers (CD11b, CD18, and CD69), human MHCII (HLA-DR) and TLR-2 and TLR-4. For both DC and monocyte analysis, events were evaluated for both their proportion of positive cells as well as for their mean fluorescence intensity (MFI) for each antibody to determine the number of cells positive for a cell surface marker and the expression quantity of that marker on the cell surface membrane, respectively.
Statistical Analysis Data are reported as the mean ± SEM. An n=9-15 was utilized for the data analysis for each staining type for each time period. An n<15 was used when data points were not available due to limitations in the staining procedure and the blood collection volumes. Data were analyzed using the statistical software program SigmaStat ® v.2.03 (SPSS Inc, Chicago, IL, USA). For multivariant comparison among groups, a one-way bright/dim monocytes to be identified on a CD14 versus CD16 density plot ANOVA was used with an all pairwise multiple comparison procedure being performed using the Fisher least significant difference method. The Kruskal-Wallis ANOVA on ranks and the Dunn's method were utilized when tests for normality or equal variance failed. Differences were considered significant at p<0.05.
Results
In this group of 15 patients undergoing hepatic resection, there were seven male and eight female subjects. The patients' mean age was 61±2 years, with 12 of the 15 having a final diagnosis of malignancy (Table I ). The length of hospital stay was 15±5 days, with a median of 9 days. Eleven patients had uneventful post-operative courses, with nine patients having no complications and two having minor complications. This included one patient who developed a superficial wound infection and one who exhibited minor symptoms from a possible withdrawal from alcohol. Two patients required readmission within 30 days of surgery for operation-related complications (one subphrenic abscess, one sympathetic pleural effusion). Finally, patient number eight required an in-hospital intravenous antibiotic treatment course for bacterial colonization of a pre-operatively placed biliary stent and a possible postoperative pneumonia, while patient number two developed an ileocolic anastomotic leak at 8 days after the initial operative procedure. There were no deaths within 30 days of surgery. The infectious complication rate was three out of 15 (20%). Four patients received blood during the study (<3 U).
Relative and Absolute Numbers of Circulating Monocyte and DC Populations and Subpopulations Patients undergoing partial hepatectomy manifested a significant leukocytosis on post-operative day 1, which subsequently normalized (Fig. 2) . The relative and absolute monocyte population significantly increased in the post-operative period (Fig. 3a, b) . Although there was an increase in both the CD16 bright and CD16 dim populations postoperatively, there was a relative decrease in the CD16 bright population as compared to CD16 dim monocytes initially post-resection. This was followed by an increase in CD16 bright monocytes as compared to the CD16 dim population on post-operative day 1, which subsequently normalized (Fig. 3a, b) .
The relative and absolute numbers of DCs declined postresection and did not significantly recover within 5 days (Fig. 4a, b) . There was a relative and absolute increase in the plasmacytoid DC2 population, as compared to the DC1 population in the immediate post-hepatectomy period. This was followed by a reversal to a predominantly DC1 phenotype on post-operative day 1, although total DC numbers were still decreased. By post-operative day 5, ldDCs were the primary circulating DC phenotype (Fig. 4a, b) .
Relative and Absolute Changes in the Activation Status of Circulating Monocyte and DC Populations and Subpopulations In general, there was no change in the monocyte expression of either CD18 or CD11b, although the latter was expected, as most monocytes were already expressing CD11b. However, there was a significant increase in the cell-surface expression of CD11b in the CD16 bright subpopulation starting on post-operative day 1, as demonstrated by a significant increase in the MFI of these cells (Fig. 5) . The absolute number of CD69 + monocytes also increased after the hepatectomy, but this appeared to be related to the overall increase in the numbers of circulating monocytes, rather than to any proportional increase in monocyte CD69 expression (data not shown).
CD86 expression was used to examine DC maturation or activation status. The DC population was subdivided into three phenotypes based upon their level of CD86 expression: CD86 − , CD86 low , and CD86 high (Fig. 6a) . CD86 expression by DCs significantly decreased in the immediate post-operative period with CD86
− expression becoming the predominant phenotype (Fig. 6b) . This was followed by CD86 low DCs becoming the predominant phenotype on post-operative day 1. By post-operative day 5, however, the relative population of CD86 high DCs had significantly increased, although an increase in their absolute concentration did not reach statistical significance (Fig. 6) .
Changes in Monocyte HLA-DR Expression There was a significant relative decrease in the HLA-DR + monocyte population post-hepatectomy (Fig. 7a) . Cell surface expression (MFI) of HLA-DR significantly declined postoperatively and then began to increase by post-operative day 3 (Fig. 8) . HLA-DR + expression on the CD16 dim monocyte population declined, but absolute reductions in the number of circulating CD16 dim HLA-DR + monocytes, as well as changes in their HLA-DR cell surface expression (based on MFI), were not seen (Fig. 7a) .
In contrast, the percentage of CD16 bright monocytes expressing HLA-DR significantly declined until postoperative day 3, when there was a significant restoration in their relative population (Fig. 7a) . This was followed by a significant decline again on post-operative day 5. The absolute numbers of CD16 bright HLA-DR + monocytes declined post-resection, but subsequently normalized, most likely due to the post-operative increase in total circulating monocytes (Fig. 7b) . More interestingly, the amount HLA-DR cell surface expression (as based on MFI) in CD16 bright monocytes significantly decreased post-resection without significant recovery (Fig. 8 ).
Relative and Absolute TLR-2 and TLR-4 Expression in Circulating Monocytes and DCs Significant differences were also found in the total number of blood monocytes expressing TLR-2 in the post-operative period, but these were generally a reflection of total monocyte numbers, as most monocytes were TLR-2 + , and there were no significant changes in the relative percentage of this population (data not shown). However, there was a significant upregulation of TLR-2 cell surface expression (MFI) beginning on post-operative day 1 in both the total and CD16 bright monocytes (Fig. 9) , an occurrence not seen in the CD16 dim subpopulation (data not shown). In addition, there was a relative increase in the percentage of TLR-4 + monocytes and TLR-4 + CD16 bright monocytes, as well as an absolute increase in the numbers of TLR-4 + monocytes and TLR-4 + CD16 bright monocytes by post-operative day 1 (Fig. 10) .
There was a significant increase in the percentage of TLR-2 + DCs on post-operative day 1 (Fig. 9) . However, the total numbers were decreased due to the overall loss of DCs bright monocytes expectedly demonstrating an inverse effect (p<0.05; a). This relative change was not necessarily reflected in the absolute number of circulating CD16 dim and CD16 bright monocytes (b). There was an absolute increase in the CD16 dim monocyte number from pre-hepatectomy (p<0.05 versus POD1 and 5) and posthepatectomy levels (p<0.001 versus POD1 and 5, p<0.05 versus POD3). There was a significant drop in the CD16 bright monocyte population post-hepatectomy (p<0.05 versus pre-hepatectomy), which was followed by a significant increase in their numbers (p<0.05 versus POD1 and 3) from the circulation during this period, and there was no difference in the cell surface of expression (MFI) of TLR-2 on these DCs (data not shown).
With the relatively small sample size, no temporal differences in cell phenotype could be identified between patients who developed infectious complications and those who did not, or in patients who received red blood cell transfusions versus those who did not. In addition, no differences were identified in those patients that underwent surgery additional to a liver resection. However, those patients with infectious complications essentially displayed exacerbations of the data presented below (data not shown).
Discussion
Changes in the numbers and phenotype of circulating cells of the innate immune system may contribute to the increased post-operative risk for infectious complications seen in patients undergoing major hepatectomy. In the DCs exhibited a relative loss post-hepatectomy followed by a relative increase on POD1 followed by another relative loss in their circulating levels (all p<0.001 except pre-hepatectomy versus POD1, p<0.05).
Absolute CD11c
+ DC counts displayed pre-hepatectomy and POD1 numbers to be different than other time points (p<0.05 versus posthepatectomy, POD3, POD5 and p<0.05 versus pre-hepatectomy and POD3, respectively). There was a significant increase in the percentage of CD123 + DCs post-hepatectomy (p<0.001), which was followed by significant decline on POD1 and 5 (p<0.001 and p<0.05 as compared to pre-hepatectomy, respectively). An absolute loss of CD123 + DCs was also observed in the post-operative period (p<0.05 pre-hepatectomy versus POD1, 3, and 5; p<0.05 post-hepatectomy versus POD1 and 3). By POD5, the percentage of circulating ldDCs increased (p<0.05 versus pre-hepatectomy, post-hepatectomy, and POD1) and became the predominant DC phenotype, although changes in the absolute numbers of these cells never reached significance present report, we examined the changes in the numbers and phenotypes of both monocytes and DCs (Table II) . By post-operative day 1, there was an increase in the total number of circulating monocytes and the percentage of monocytes expressing CD16, and these cells were activated based on their increased CD11b expression. There was also upregulation of TLR-2 and TLR-4 expression, while there was a simultaneous decline in their HLA-DR expression. Unlike circulating monocytes, DC numbers significantly declined after surgery, shifting from a pre-operative DC1 phenotype (myeloid) to a post-resection DC2 phenotype (plasmacytoid) and back to a DC1 phenotype on postoperative day 1. As the post-operative period progressed, however, the phenotype of the circulating DCs shifted to a more ldDC phenotype by post-operative day 5. These cells initially appeared to have a reduced activation status, but cell surface CD86 expression increased by day 5. In addition, there was an increased percentage of circulating DCs expressing the TLR2 receptor (Table II) . Altogether, these data confirm that the innate immune system was significantly altered in the immediate post-resection and post-operative periods.
Changes in the monocyte phenotype, specifically the CD16 bright population, in the post-operative period were somewhat unexpected for patients undergoing hepatic resection. Although the leukocytosis on post-operative day 1 and the increased relative and absolute levels of monocytes in the post-operative period were not surprising, the specific loss of HLA-DR expression on CD16 bright monocytes was unanticipated. It is possible that the loss of HLA-DR expression on monocytes represented an efflux of less mature cells from other compartments in response to surgical stress, but an increase in immature monocytes should have been associated with a decrease in monocyte CD16 expression. This was not observed; thus, we believe our data demonstrates a specific downregulation of HLA-DR on circulating monocytes. HLA-DR downregulation is thought to contribute to reduced antigen presentation capability and immune paralysis [47] . Monocyte HLA-DR downregulation has been reported in cardiopulmonary bypass operations and can predict patients at elevated risk for post-operative infections [15, 35, 39, 43] . Although data from our laboratory have demonstrated that both sepsis and gastrointestinal surgery decrease monocyte HLA-DR expression, only sepsis decreases HLA-DR expression on CD16 bright monocytes [27, 47] . Abdominal surgery has been generally characterized by an increased monocyte responsiveness, consistent with − cells were determined by the appropriate isotype control. ii CD86 low and CD86 high DC populations were easily identified after activating DCs in whole blood by incubating them with 1 µg/ml of LPS for 1 h. b Alterations in DC CD86 expression. There was a significant increase in the relative CD86
− DC population posthepatectomy as compared to all other time points (p<0.05). However, the absolute numbers of these cells declined (p<0.05 pre-hepatectomy versus POD1) due to the overall loss of circulating DCs. The relative number of CD86 low DCs was greater pre-hepatectomy and on POD1 as compared to post-hepatectomy, POD3 and POD5 (p<0.05). This was also reflected in the absolute numbers, with a significant increase on POD1 as compared to post-hepatectomy levels (p<0.05). The proportion CD86
high increased later in the post-operative period (p< 0.05 POD3 versus pre-hepatectomy; POD5 versus pre-hepatectomy, post-hepatectomy and POD1), although change in the absolute number of mature CD86
high DCs did not reach significance bright monocytes. HLA-DR was significantly downregulated on all monocytes (p<0.001 pre-hepatectomy versus post-hepatectomy; p<0.05 pre-hepatectomy versus POD1), which then increased, later in the post-operative period (p<0.05 post-hepatectomy versus POD3 and 5). CD16 dim monocytes never significantly altered their amount of HLA-DR cell surface expression. However, CD16 bright monocytes significantly downregulated their expression of HLA-DR post-operatively and never recovered to pre-resection levels (p<0.001 pre-hepatectomy versus POD1; p<0.05 pre-hepatectomy versus post-hepatectomy, POD3 and 5) activation and/or priming. For example, LPS-induced monocyte tumor necrosis factor-alpha (TNF-α) production has been shown to increase after gastrointestinal surgery [2, 11, 30] . Since our post-hepatectomy patients have a relative and absolute increase in circulating monocytes that shifts to a CD16 bright phenotype, as well as having an increased activation status, it would appear that the innate immune system was activated by the surgical resection of the liver. However, the observation that HLA-DR expression, a marker of the cell's capacity to present antigens and to drive an acquired immune response, was reduced complicates that earlier observation. In this regard, the monocytic phenotype observed after major liver resection is more similar to that seen in sepsis or with cardiopulmonary bypass than standard general surgery operations. These multiple disparate findings would imply that these patients may be manifesting complex phenotypic patterns consistent not only with monocyte activation, but also with anergy and suppression of acquired immunity.
Similarly, hepatectomy patients demonstrated a significant decline in their circulating DC population immediately following resection. Specific analysis of DC kinetics and phenotypic changes in the immediate post-operative period with other types of surgery is limited, but similar decreases have been seen in patients following gastrointestinal tract surgery [7] . The pattern seen in hepatectomy patients is notably different than that seen in laparoscopic cholecystectomy, open cholecystectomy, and elective hysterectomy patients. These patients actually have an increase in circulating DC numbers intra-operatively, with the restoration of normal DC concentrations not occurring until postoperative day 2 or 3, and with DC concentrations not declining to the levels displayed by the hepatectomy patients [20] . In addition, there is an eventual phenotypic shift to CD11c
− DCs. We have labeled these cells ldDCs, a term fashioned by Hagendorens et al., as our CD11c − CD123 − DCs correlate with their described CD11c − CD123 low ldDCs [18] . Although the function of these cells is presently unknown, they are the predominant DC phenotype found in cord blood, and they are found to be in higher numbers in pediatric patients with atopic dermatitis as compared to healthy and asthmatic children bright monocytes significantly increase on POD1 (p< 0.05 pre-hepatectomy versus POD1 and POD3) [18] . The shift to ldDCs in the hepatectomy patient is most likely due to a combination of DC migration out of the bloodstream as well as an effort to replenish the circulating DC population from the patient's progenitor cells. Regardless, the appearance of these ldDcs represents a shift away from a classical Th1 response. These shifts are not seen in patients who are undergoing less invasive operations [20] .
Most circulating DCs are not activated, but rather are usually in a precursor (CD86
state. The function of these circulating DC1s is to migrate to areas of inflammation prior to complete maturation. After encountering a stimulus or antigen, these DCs will undergo a number of functional and phenotypic changes, including decreased endocytosis, upregulation of membrane MHCII and co-stimulatory molecules, and increased specific cytokine expression. These phenotypic changes result in the DC becoming a potent stimulator of T lymphocytes, and mature DCs also have an increased ability to migrate to lymphoid tissue, usually through the lymph system [10] . The loss of precursor CD86
− and immature CD86 low DCs in the circulation could reflect migration of these immature cells out of the bloodstream to areas of infection or inflammation. Interestingly, we observed a significant decrease in the percentage of CD86 − and CD86 low DCs along with a significant increase in the percentage of CD86 + DCs by post-operative day 5. Although this may represent an increase in the activation status of the circulating DCs, ldDCs make up the primary DC phenotype at this time point. Data from our laboratory as well as others have demonstrated that DCs, which are phenotypically mature (i.e., express high levels of costimulatory molecules) but are functionally immature (in terms of cytokine expression and ability to induce Th1 or Th2 responses), can induce the expansion of T-regulatory cell populations (unpublished data) [1, 10] . Like activated monocytes lacking HLA-DR, these DCs may inhibit an appropriate response to infection post-hepatectomy.
TLRs are a family of ancient and conserved receptors among organisms that recognize pathogen-associated molecular patterns (PAMPs), which are conserved structural components found in many microorganisms [28, 44, 49] . TLR-2 has been shown to recognize Gram-positive bacterial, mycobacterial, fungal, and spirochetal cell wall. TLR-4 recognizes the Gram-negative PAMP LPS as well as other endogenous ligands such as fibrinogen, neutrophil elastase, and high mobility group box 1 [8, 32, 38, 40, 42, 52] . Other studies have demonstrated a significant suppression of TLR-2 and TLR-4 surface expression after alimentary tract operations [21] . Cardiopulmonary bypass produces an initial downregulation of TLR-2 and TLR-4 expression in the immediate post-operative period followed by an upregulation of both TLRs on post-operative day 1 [9] . We and others have demonstrated during sepsis that there is an increase in monocyte TLR-2 and TLR-4 expression [3, 19, 46, 48] . In this report, we again have chosen to analyze TLR-2 and TLR-4 for the reason that this would most likely include the TLRs for the most commonly encountered organisms in post-operative infection (Gram-positive andnegative bacteria), as well as giving us a reference point from which to compare our data. Our data displays that there is also increased expression of TLR-2 on monocytes as well as an increase in the percentage of TLR-4 + monocytes in the circulation consistent with an increased immune surveillance during the post-operative period. It should be noted that responses in TLR-2 and TLR-4 expression do not represent changes in all TLR expression, such as TLR-3, TLR-5, TLR-7, TLR-8, and TLR-9, which bind to other specific PAMPs.
The changes seen in the numbers and phenotype of monocytes and DCs in post-hepatectomy patients are most likely multifactorial. The liver is the principal source of complement and acute phase reactants, such as IL-6, both of which are essential components of innate immunity. In addition, some may be related to the inflammatory response previously noted to occur following liver resection. In patients undergoing liver resection, increased portal IL-6 and systemic IL-8 concentrations correlated with hepatocyte injury [24] . Patients who developed systemic inflammatory response syndrome (SIRS) after hepatectomy exhibited elevated serum post-operative IL-6 levels [31] . However, some studies have demonstrated no difference in the magnitude of the inflammatory response, as determined by plasma IL-6, IL-8, secretory phospholipase A2 (sPLA2) and elastase levels, in hepatectomy patients as compared to other major abdominal operations. These data suggest that the inflammatory response may not be responsible for the increased complication rate observed in these patients [51] . Other factors may play a role, including bacterial translocation. In a porcine model of liver ischemia, partial liver resection, and liver reperfusion, bacterial translocation to the thoracic duct contributed to any subsequent bacteremia and SIRS response [26] . All patients in this study underwent a standardized 30 min of hepatic vascular inflow occlusion. The normal human liver tolerates up to an hour of warm ischemia during hepatectomy without major sequelae; however, this short period of ischemia and subsequent reperfusion may play a role in the observed response. Finally, we cannot rule out the possibility that the observed response is specifically related to liver malignancy and its operative management, as most of our patients had a final diagnosis of cancer.
Conclusion
Our data demonstrate that hepatectomy is associated with a complex monocytic phenotype, consistent with activation of monocyte populations, increased immune surveillance, and simultaneous reduced antigen presentation capacity. DC populations are equally affected, with the ultimate generation of a novel ldDC population expressing increased levels of T-cell costimulatory molecules. These overall changes in the phenotype of effector cell populations would theoretically place the post-hepatectomy patient at increased risk of an exaggerated secondary inflammatory response to a subsequent infectious challenge, with a reduced capacity to stimulate a Th1-acquired immune response. These changes may contribute to the increased risk of infectious complications in this patient population.
